ponvory
janssen-cilag international n.v. - ponesimod - heila-og mænusigg, köstum tilkynnt - Ónæmisbælandi lyf - ponvory is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features.
minjuvi
incyte biosciences distribution b.v. - tafasitamab - lymphoma, large b-cell, diffuse - Æxlishemjandi lyf - minjuvi is indicated in combination with lenalidomide followed by minjuvi monotherapy for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) who are not eligible for autologous stem cell transplant (asct).
uplizna
horizon therapeutics ireland dac - inebilizumab - neuromyelitis optica - Ónæmisbælandi lyf - uplizna is indicated as monotherapy for the treatment of adult patients with neuromyelitis optica spectrum disorders (nmosd) who are anti-aquaporin 4 immunoglobulin g (aqp4-igg) seropositive (see section 5.
bendamustine accord stofn fyrir innrennslisþykkni, lausn 2,5 mg/ml
accord healthcare b.v. - bendamustinum hýdróklóríð - stofn fyrir innrennslisþykkni, lausn - 2,5 mg/ml
certican tafla 0,75 mg
novartis healthcare a/s - everolimusum inn - tafla - 0,75 mg
certican tafla 0,5 mg
novartis healthcare a/s - everolimusum inn - tafla - 0,5 mg
certican tafla 0,25 mg
novartis healthcare a/s - everolimusum inn - tafla - 0,25 mg
bendamustine medac stofn fyrir innrennslisþykkni, lausn 2,5 mg/ml
medac gesellschaft für klinische spezialpräparate gmbh - bendamustinum hýdróklóríð - stofn fyrir innrennslisþykkni, lausn - 2,5 mg/ml
dexamethasone hameln stungulyf, lausn 4 mg/ml
hameln pharma gmbh - dexamethasonum natríumfosfat - stungulyf, lausn - 4 mg/ml
ovestin leggangakrem 1 mg/g
aspen pharma trading limited - estriolum inn - leggangakrem - 1 mg/g